Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Vitrolife Group has today published its Annual and Sustainability Report for 2023. The Annual and Sustainability Report is now available digitally in ...
The shareholders of Vitrolife AB (publ), corporate identity number 556354-3452 (`the Company') are hereby invited to attend the Annual General...
Fourth quarter Sales of SEK 904 (855) million, an increase of 6%. In local currencies the growth was 5%. Sales, in local currencies increased by 16%...
Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the fourth quarter and full year report 2023. The presentation...
Vitrolife AB (publ) today announced that it will host a Capital Markets Day presentation for the investment community on 12 December 2023,...
Third quarter Sales of SEK 848 (798) million, an increase of 6%, or 7% excluding discontinued business. In local currencies the growth was 2% and...
Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q3, 2023. The presentation will be held in...
The following people have been appointed as members of the election committee for Vitrolife AB for the Annual General Meeting in 2024: Niels...
Bronwyn Brophy O´Connor, CEO Vitrolife AB, has acquired 19,350 shares worth 2,495,957 SEK. The total holdings of shares amount to 19,350. The...
Maria Forss, has resigned from her position in the Vitrolife Group as she will assume the role of CEO BICO Group AB. We are currently working on a...
According to plan and as previously announced, Henrik Blomquist will step down as Chairman of the Board of Vitrolife AB (publ) and the Board of...
Second quarter Sales of SEK 905 (829) million, an increase of 9%, or 10% excluding discontinued business. In local currencies the growth was 3% and...
Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q2, 2023. The presentation will be held in...
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: Resolution in accordance with the Board's...
Vitrolife Group has today published its Annual and Sustainability Report for 2022. The Annual and Sustainability Report is now available digitally in ...
The shareholders of Vitrolife AB (publ) are hereby invited to attend the Annual General Meeting of shareholders on Thursday 27 April 2023 at 4.00 pm...
Fourth quarter Sales of SEK 855 (514) million, corresponding to an increase of 66% in SEK, whereof organic growth 11%, acquired growth 37% and...
Bronwyn Brophy is Irish and has extensive experience of leading positions in Global Life Science and Medtech companies such as Thermo Fisher...
Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the Year-end report, 2022. The presentation will be held in...
Vitrolife's CEO Thomas Axelsson has today acquired 12,000 shares worth 2,124,000 SEK. The total holdings of shares amount to 25,000. The transaction...
Vitrolife's CEO Thomas Axelsson has today acquired 12,000 shares worth 2,124,000 MSEK. The total holdings of shares amount to 25,000. The transaction ...
Third quarter Sales of SEK 798 (406) million, corresponding to an increase of 97% in SEK, whereof acquired growth 75% and currency effect 20%. Sales...
The following people have been appointed as members of Vitrolife's election committee for the Annual General Meeting in 2023: Niels Jacobsen,...
Today, Thomas Axelsson, CEO of Vitrolife AB (publ), informed the Board of Directors of his desire and intention to retire and be released from his...
Second quarter Sales of SEK 829 (382) million, corresponding to an increase of 117% in SEK, whereof currency effect 18%, acquired growth 80% and...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.